Atom Bioscience is a clinical-stage biotechnology company.
Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 5, 2022 | Series C | $45M | 1 | — | — | Detail |
Jun 21, 2018 | Series A | $3.07M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Unifortune | — | Series C |
Ch-gemstone capital | — | Series A |